AI assistant
Sending…
Anixa Biosciences Inc — Director's Dealing 2017
Jun 5, 2017
34117_dirs_2017-06-05_dee89328-a383-4212-b2cf-70a1669910df.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ITUS Corp (ITUS)
CIK: 0000715446
Period of Report: 2017-06-02
Reporting Person: BERMAN ROBERT ANDREW (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-06-02 | Common Stock | P | 100 | $0.85 | Acquired | 51653 | Direct |
| 2017-06-02 | Common Stock | P | 9900 | $0.88 | Acquired | 61553 | Direct |
More from Anixa Biosciences Inc
Regulatory Filings
2026
Mar 11
Interim / Quarterly Report
2026
Mar 9
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Jan 29
Proxy Solicitation & Information Statement
2026
Jan 28
Regulatory Filings
2026
Jan 12
Annual Report
2026
Jan 12
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6
Director's Dealing
2026
Jan 6